|[February 12, 2014]
Research and Markets: Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/3t5jtr/glucose)
has announced the addition of the "Glucose
Monitoring Device Market to 2019 - Technology Adoption and Increasing
Health Awareness Serve as Distinct Regional Growth Drivers"
report to their offering.
Glucose Monitoring Devices Market: Asia-Pacific to Boost Moderate Growth
The global glucose monitoring devices market value will experience a
moderate increase from $9.9 billion in 2012 to $13.7 billion by 2019, at
a Compound Annual Growth Rate (CAGR) of 5%
According to the company's latest report*, emerging countries, such as
China and India, show the most potential for market growth, as they have
the largest diabetic populations consisting of 92 million and 63 million
In fact, the Asia-Pacific market for glucose monitoring is expected to
double from $1.5 billion in 2012 to $3 billion by 2019, at a CAGR of
10%. Still, the US and Europe will continue to lead this setting by
2019, with shares of 34% and 40%, respectively.
Srikanth Venkataraman, report analyst, says: Rapid urbanization and
changes in lifestyle habits have made people in developing countries
especially vulnerable to disorders such as diabetes. Hwever, poor
healthcare infrastructure, urban-rural disparity and a lack of skilled
healthcare professionals have previously limited the adoption and use of
devices for the prevention and treatment of diabetes in these markets.
The authors now expect the increasing awareness of the importance of
glucose monitoring, along with technical innovations minimizing the
blood required for glucose testing, to drive the adoption of such
devices in the Asia-Pacific region during the forecast period.
Venkataraman says: One of the key technological developments in the
diabetes care industry is Continuous Glucose Monitoring (CGM), which
helps patients to measure glucose levels regularly, unlike traditional
devices. CGM devices are programmed to alert users to low or high
glucose levels, allowing for timely medication and reducing any risk of
associated complications due to undesired changes in glycemic levels.
With diabetes becoming an increasingly major burden globally, the
authors believe that early detection through regular monitoring can
improve the control and treatment of the disease.
This report provides information on market size for the three glucose
monitoring devices market segments: blood glucose meters, blood glucose
testing strips, and lancets. Countries covered include the US, Canada,
Germany, France, Italy, Spain, the UK, Japan, China, India, Australia
Key Topics Covered:
List of Tables
List of Figures
Global Glucose Monitoring Device Market: Device Overview
Global Glucose Monitoring Device Market: Market Characterization
Global Glucose Monitoring Device Market: Segment Analysis and Forecasts
Global Glucose Monitoring Device Market: Country Analysis and Forecasts
Global Glucose Monitoring Device Market: Reimbursement System
Global Glucose Monitoring Device Market: Competitive Landscape
Global Glucose Monitoring Device Market: Product Pipeline Analysis
Global Glucose Monitoring Device Market: Consolidation Landscape
- Abbott Laboratories
- Arkay, Inc.
- Bayer Healthcare AG
- F. Hoffmann-La Roche Ltd.
For more information visit http://www.researchandmarkets.com/research/3t5jtr/glucose
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To TMCnet.com's Homepage ]